David R. Spigel’s presentation at the 2024 ASCO on crucial developments in lung cancer treatment – Sarah Cannon Research Institute

Sarah Cannon Research Institute shared a post on LinkedIn:

“David R. Spigel, presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting highlighted crucial developments in lung cancer treatment. From innovative drug trials to promising long-term results, our research continues to drive progress in oncology. Read more about these highlights here: IASLC FOUNDATION ASCO 2024 Highlights.”

Additional information
Source: Sarah Cannon Research Institute/LinkedIn